Drug loading into and drug release from pH- and temperature-responsive cylindrical hydrogels

Fabrication and characterization of tamarind seed gum based novel hydrogel for the targeted delivery of omeprazole magnesium

The tamarind seed gum based novel hydrogel was fabricated by varying concentration of polymer, monomer and crosslinker for the targeted delivery of omeprazole magnesium at stomach pH of 1.5. The free radical graft copolymerization of 2-acrylamido-2-methyl propane sulfonic acid with tamarind seed gum backbone resulted in hydrogel. The formation of sulfonic acid pendant groups in hydrogel was observed by the existence of an infrared absorption band at 1152 cm-1 for SO group. The conversion to semicrystalline nature on incorporation of drug evidenced by powder X-ray diffraction studies with peaks at 2θ = 20.4° 31.5° and 52.2°. The scanning electron microscopy images showed bigger voids which narrowed down for drug loaded matrix, supported by the presence of a peak for magnesium in the energy dispersive X-ray spectroscopy. The greatest swelling was observed at pH 7 with second-order rate constant 1.5371 (g/g)/min and drug release was found to be 97.85 ± 1 % over 1200 min at pH 1.5. The drug release transport was found combination of diffusion and erosion of polymer chain to be super case II diffusion and Hill equation model was good fit. The hydrogel drug conjugate found to be non-toxic at tested concentrations (17 mg/50 mg) on in-vivo testing in Drosophila model.

Smart Hydrogel Bilayers Prepared by Irradiation

Environment-responsive hydrogel actuators have attracted tremendous attention due to their intriguing properties. Gamma radiation has been considered as a green cross-linking process for hydrogel synthesis, as toxic cross-linking agents and initiators were not required. In this work, chitosan/agar/P(N-isopropyl acrylamide-co-acrylamide) (CS/agar/P(NIPAM-co-AM)) and CS/agar/Montmorillonite (MMT)/PNIPAM temperature-sensitive hydrogel bilayers were synthesized via gamma radiation at room temperature. The mechanical properties and temperature sensitivity of hydrogels under different agar content and irradiation doses were explored. The enhancement of the mechanical properties of the composite hydrogel can be attributed to the presence of agar and MMT. Due to the different temperature sensitivities provided by the two layers of hydrogel, they can move autonomously and act as a flexible gripper as the temperature changes. Thanks to the antibacterial properties of the hydrogel, their storage time and service life may be improved. The as prepared hydrogel bilayers have potential applications in control devices, soft robots, artificial muscles and other fields.

Rational Development of a Novel Hydrogel as a pH-Sensitive Controlled Release System for Nifedipine

This work depicts the rational development (in-silico design, synthesis, characterization and in-vitro evaluation) of polyvinyl alcohol hydrogels (PVAH) cross-linked with maleic acid (MA) and linked to γ-cyclodextrin molecules (γ-CDPVAHMA) as systems for the controlled and sustained release of nifedipine (NFD). Through computational studies, the structural blocks (PVA chain + dicarboxylic acid + γ-CD) of 20 different hydrogels were evaluated to test their interaction energies (ΔE) with NFD. According to the ΔE obtained, the hydrogel cross-linked with maleic acid was selected. To characterize the intermolecular interactions between NFD and γ-CDPVAHMA, molecular dynamics simulation studies were carried out. Experimentally, three hydrogel formulations with different proportions of γ-CD (2.43%, 3.61% and 4.76%) were synthesized and characterized. Both loading and release of NFD from the hydrogels were evaluated at acid and basic pH. The computational and experimental results show that γ-CDs linked to the hydrogels were able to form 1:1 inclusion complexes with NFD molecules. Finally, γ-CDPVAHMA-3 demonstrated to be the best pH-sensitive release platform for nifedipine. Its effectiveness could significantly reduce the adverse effects caused by the anticipated release of NFD in the stomach of patients.